CLDND1 anticorps (Middle Region)
Aperçu rapide pour CLDND1 anticorps (Middle Region) (ABIN951560)
Antigène
Voir toutes CLDND1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 50-80, Middle Region
-
Specificité
- This antibody reacts to CLDND1.
-
Réactivité croisée (Details)
- Species reactivity (tested):Human and Mouse.
-
Purification
- Affinity chromatography on Protein A
-
Immunogène
- KLH conjugated synthetic peptide between 50~80 amino acids from the Central region of human CLDND
-
Isotype
- Ig Fraction
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.25 mg/mL
-
Buffer
- PBS, 0.09 % (W/V) sodium azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freezing and thawing.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- CLDND1 (Claudin Domain Containing 1 (CLDND1))
-
Autre désignation
- CLDND1
-
Sujet
- CLDND1 is widely distributed in the adult CNS with highest expression in the corpus callosum, caudate nucleus, cerebral cortex, medulla, putamen, spinal cord, substantia nigra and subthalamic nucleus. Weak expression has been detected in the adult heart. There are 2 named isoforms produced by alternative splicing.Synonyms: C3orf4, Claudin domain-containing protein 1, GENX-3745, HSPC174, PRO6000, PSEC0054, UNQ2511
-
Poids moléculaire
- 28603 Da
-
ID gène
- 56650
-
NCBI Accession
- NP_001035271
Antigène
-